Download Mobile App

Video Library

DeepSight Demonstrates Groundbreaking Ultrasound-Guided Needle Technology

By MedImaging International staff writers
Posted on 26 Nov 2023

Image: DeepSight’s NeedleVue ultrasound-assisted needle guidance technology is on display at RSNA 2023 (Photo courtesy of DeepSight)

DeepSight Technology (Santa Clara, CA, USA) is presenting its groundbreaking NeedleVue solution at RSNA 2023, providing a comprehensive insight into how this technology is poised to reshape and revolutionize the future of interventional procedures. This state-of-the-art ultrasound-guided needle technology ushers in a new era of precision and safety in the field of directed interventional tool guidance which has been struggling with complexities for several decades.

DeepSight's proprietary NeedleVue solution integrates innovative sensor technology with most interventional devices, facilitating real-time verification of placement and significantly reducing procedural guesswork. Conventional technologies usually create challenges like laborious calibration processes, reduced sensitivity, and the need for precise angles of incidence. NeedleVue delivers improvement across the board with its omnidirectional functionality at any plausible ultrasound depth, enhancing functionality and ease of use in a true "plug-and-play" solution.

DeepSight's NeedleVue helps achieve confident results by eliminating guesswork and ensuring verifiable placement in real time. This plug-and-play system eliminates the need for complicated setups or extensive training while its omnifunctionality at any ultrasound depth broadens the scope of its applicability across various medical scenarios. DeepSight's NeedleVue marks a clear paradigm shift in needle guidance technology by delivering real-time, precision needle tracking that is as portable as it is easy to use. The technology meets the need for combining operational efficacy with optimized patient outcomes among healthcare providers.

"NeedleVue not only signifies a monumental leap in the evolution of interventional tool guidance but also substantiates our steadfast commitment to ensuring procedural success - benefiting patients, clinicians, and healthcare providers alike,” said Nader Sadrzadeh, the Chief Executive Officer at DeepSight Technology. “In a reality where procedural confidence is paramount, our solution stands out as a beacon of precision and reliability, effortlessly aligning with the multifaceted demands of modern healthcare."

Related Links:
DeepSight Technology